The vital role of education and information in patients receiving capecitabine (Xeloda)

European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Ian ChauPierre Fumoleau

Abstract

Use of oral capecitabine (Xeloda) as home-based therapy leads to savings in healthcare resources and costs and oral chemotherapy is preferred by many cancer patients over intravenous (i.v.) 5-FU. The demands of patient management for oral therapy differ significantly from those of i.v. chemotherapy. Consequently, cancer programmes have begun to implement strategies to meet these unique demands, offer educational programmes for clinicians who prescribe capecitabine, and consider potential changes in staff responsibilities. To encourage patients to take an active part in their care, which is vital with home-based oral therapy, they must be properly informed about their treatment. Patient information needs to be specific for the cancer type and relevant for the country. Various tools have been developed, including prescription guides, diary cards and support kits, which are useful in reinforcing verbal discussions about the use of capecitabine and in helping patients to manage their treatment. Nurses have a vital role to play in encouraging the optimal use of capecitabine and prompt management of adverse events, thereby enabling the patient to achieve a better clinical outcome and maintain an improved quality of life in the home e...Continue Reading

References

Jun 1, 1980·Annals of Internal Medicine·B R CassilethV March
Sep 21, 1996·BMJ : British Medical Journal·C MeredithL Fallowfield
Oct 1, 1996·Journal of Advanced Nursing·J D Cortis, A E Lacey
Apr 6, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C TwelvesUNKNOWN Xeloda Colorectal Cancer Study Group
May 2, 2002·Journal of the National Cancer Institute·Ann H PartridgeEric P Winer
Jun 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J CassidyUNKNOWN Capecitabine Colorectal Cancer Study Group
Oct 1, 2003·Journal of Medical Internet Research·Melisa J SatterlundAnn K Sandgren
Sep 3, 2004·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Hilde MarséSonia Valverde
Sep 3, 2004·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Sara Faithfull, Paula Deery

❮ Previous
Next ❯

Citations

Jun 8, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sultan Kav, Humeyra Bostanci
Jun 17, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sven SimonsUlrich Jaehde
Nov 16, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J M VieitezE Díaz-Rubio
Apr 14, 2011·BMC Cancer·Sarah SchottMichael H Eichbaum
Dec 17, 2008·Women's Health·Mariko Morishita, Robert C Leonard
Feb 5, 2015·Current Medical Research and Opinion·Claus-Christoph SteffensDorothee Guggenberger
Jun 24, 2010·Cancer Treatment Reviews·Giuseppe Luigi BannaFrancesco Ferraù
Jan 27, 2010·Clinical Colorectal Cancer·Weijing Sun
Mar 11, 2008·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·J Baker, J A Ajani
Dec 26, 2006·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·A MacLeodL MacDonald
Mar 19, 2016·Journal of Clinical Nursing·Claire O'GormanMartina Gooney
Sep 3, 2004·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Sara Faithfull, Paula Deery
Sep 3, 2004·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Bonnie-Mae Gerbrecht, Tuija Kangas
Oct 8, 2013·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Mukadder Mollaoğlu, Gülyeter Erdoğan
Dec 29, 2013·Oncology Nursing Forum·Janna C Roop, Horng-Shiuann Wu
Aug 15, 2009·The Oncologist·Nicholas ThatcherUNKNOWN U.K. Erlotinib Skin Toxicity Management Consensus Group
May 2, 2008·The Oncologist·Claus-Henning KöhnePhilippe Rougier
Oct 7, 2006·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Sarah M GressettFred Hardwicke
Dec 16, 2006·British Journal of Community Nursing·Paula Escalada, Peter Griffiths
Mar 31, 2015·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Zümrüt Akgün Şahin, Seher Ergüney
Jun 10, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·C RieseW Baumann

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Bonnie-Mae Gerbrecht, Tuija Kangas
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Sara Faithfull, Paula Deery
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society
Hilde MarséSonia Valverde
Journal of the National Cancer Institute
Ann H PartridgeEric P Winer
Annals of Oncology : Official Journal of the European Society for Medical Oncology
J CassidyCapecitabine Colorectal Cancer Study Group
© 2021 Meta ULC. All rights reserved